AGTC - アプライド・ジェネティック・テクノロジ―ズ (Applied Genetic Technologies Corporation)

AGTCのニュース

   Earnings Preview: Applied Genetic Technologies (AGTC) Q3 Earnings Expected to Decline  2020/04/28 16:34:06 Zacks Investment Research
Applied Genetic Technologies (AGTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Applied Genetic Technologies' Shares March Higher, Can It Continue?  2020/04/22 11:20:00 Zacks Investment Research
As of late, it has definitely been a great time to be an investor in Applied Genetic Technologies.
   AGTC Announces Completion of Enrollment in the Two Highest Dose Groups of its Ongoing Phase 1/2 Clinical Trial in Patients with X-Linked Retinitis Pigmentosa  2020/02/19 12:00:00 GlobeNewswire
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology…
   Refrigerated Cargo Is Being Diverted From Chinese Ports  2020/02/17 22:09:49 Benzinga Feeds
The initial assessment of the coronavirus effect on ocean shipping was: It will slash Chinese exports of containerized, factory-made goods and reduce China's import demand for industrial and energy bulk commodities. As it turns out, that appraisal missed a big part of the fallout picture. The Chinese population still has the same demand for food, but a major logistical hurdle has emerged to the import of perishables — and the consequences are reverberating across global agricultural export markets, including in the U.S. Perishables are imported in refrigerated containers or "reefers." When they're unloaded at the destination terminal, they must be connected to power via "reefer plugs" until they're picked up by trucks. Terminals only have so many reefer plugs, and given delays in inland truck transport due to coronavirus restrictions, reefer plugs are now full in several top Chinese ports. Peter Friedmann, executive director of the Agriculture Transport Coalition (AgTC), told FreightWaves, "The challenge for our AgTC members who export refrigerated exports such as pork, beef and poultry, as well as dry cargo such as hay and lumber, is lack of capacity of the supply chain.
   The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs  2020/02/06 12:47:50 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 5.) Alector Inc (NASDAQ: ALEC ) (announced granting of Fast Track Designation to its AL101 for the treatment of patients with frontotemporal dementia) Arvinas Inc (NASDAQ: ARVN ) Ascendis Pharma A/S (NASDAQ: ASND ) Biogen Inc (NASDAQ: BIIB ) (won patent challenge on multiple sclerosis drug Tecfidera) BioXcel Therapeutics Inc (NASDAQ: BTAI ) (announced FDA clearance of IND for BXCL501 to treat opioid withdrawal symptoms) ChemoCentryx Inc (NASDAQ: CCXI ) Eli Lilly And Co (NYSE: LLY ) Insmed Incorporated (NASDAQ: INSM ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Molecular Templates Inc (NASDAQ: MTEM ) Novo Nordisk A/S (NYSE: NVO ) (reacted to quarterly results ) Profound Medical Corp (NASDAQ: PROF ) (announced retirement of bank debt ahead of schedule) PTC Therapeutics, Inc (NASDAQ: PTCT ) Quest Diagnostics Inc (NYSE: DGX ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Revance Therapeutics Inc (NASDAQ: RVNC ) Theravance Biopharma Inc (NASDAQ: TBPH ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks that hit 52-week lows Feb. 5.) Endologix, Inc. (NASDAQ: ELGX ) Salarius Pharmaceuticals Inc (NASDAQ: SLRX ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) See also: The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus Stocks In Focus Sanofi's Multiple Sclerosis Drug Aces Midstage Trial; Q4 Sales, Net Income Rise Sanofi SA (NASDAQ: SNY ) said a Phase 2b study that evaluated its investigational BTK inhibitor SAR442168 for multiple sclerosis met the primary endpoint, …
   AGTC Announces Completion of Enrollment in the Two Highest Dose Groups of its Ongoing Phase 1/2 Clinical Trial in Patients with X-Linked Retinitis Pigmentosa  2020/02/19 12:00:00 GlobeNewswire
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology…
   Refrigerated Cargo Is Being Diverted From Chinese Ports  2020/02/17 22:09:49 Benzinga Feeds
The initial assessment of the coronavirus effect on ocean shipping was: It will slash Chinese exports of containerized, factory-made goods and reduce China's import demand for industrial and energy bulk commodities. As it turns out, that appraisal missed a big part of the fallout picture. The Chinese population still has the same demand for food, but a major logistical hurdle has emerged to the import of perishables — and the consequences are reverberating across global agricultural export markets, including in the U.S. Perishables are imported in refrigerated containers or "reefers." When they're unloaded at the destination terminal, they must be connected to power via "reefer plugs" until they're picked up by trucks. Terminals only have so many reefer plugs, and given delays in inland truck transport due to coronavirus restrictions, reefer plugs are now full in several top Chinese ports. Peter Friedmann, executive director of the Agriculture Transport Coalition (AgTC), told FreightWaves, "The challenge for our AgTC members who export refrigerated exports such as pork, beef and poultry, as well as dry cargo such as hay and lumber, is lack of capacity of the supply chain.
   The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs  2020/02/06 12:47:50 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 5.) Alector Inc (NASDAQ: ALEC ) (announced granting of Fast Track Designation to its AL101 for the treatment of patients with frontotemporal dementia) Arvinas Inc (NASDAQ: ARVN ) Ascendis Pharma A/S (NASDAQ: ASND ) Biogen Inc (NASDAQ: BIIB ) (won patent challenge on multiple sclerosis drug Tecfidera) BioXcel Therapeutics Inc (NASDAQ: BTAI ) (announced FDA clearance of IND for BXCL501 to treat opioid withdrawal symptoms) ChemoCentryx Inc (NASDAQ: CCXI ) Eli Lilly And Co (NYSE: LLY ) Insmed Incorporated (NASDAQ: INSM ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Molecular Templates Inc (NASDAQ: MTEM ) Novo Nordisk A/S (NYSE: NVO ) (reacted to quarterly results ) Profound Medical Corp (NASDAQ: PROF ) (announced retirement of bank debt ahead of schedule) PTC Therapeutics, Inc (NASDAQ: PTCT ) Quest Diagnostics Inc (NYSE: DGX ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Revance Therapeutics Inc (NASDAQ: RVNC ) Theravance Biopharma Inc (NASDAQ: TBPH ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks that hit 52-week lows Feb. 5.) Endologix, Inc. (NASDAQ: ELGX ) Salarius Pharmaceuticals Inc (NASDAQ: SLRX ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) See also: The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus Stocks In Focus Sanofi's Multiple Sclerosis Drug Aces Midstage Trial; Q4 Sales, Net Income Rise Sanofi SA (NASDAQ: SNY ) said a Phase 2b study that evaluated its investigational BTK inhibitor SAR442168 for multiple sclerosis met the primary endpoint, …
   Ag Shippers Want More Container "Free Time" During Coronavirus Outbreak  2020/02/03 21:33:42 Benzinga Feeds
A group of American agriculture and forest products shippers wants the ocean carriers in the U.S.-China trade to extend the "free-time" deadlines for containers delayed in marine terminals due to the impact of the coronavirus on international shipping. "While this is open-ended, our U.S. exporters need assurance they will not be charged detention (per diem) or demurrage while the supply chain remains dysfunctional due to the Coronavirus," wrote Peter Friedmann, executive director of the Washington-based Agriculture Transportation Coalition (AgTC) in a letter to the ocean container carriers on Monday. Demurrage pertains to the time an import container sits in a container terminal, with carriers responsible for collecting penalties on behalf of the marine terminals. Detention, also known as per diem, relates to shippers holding containers for too long outside the marine terminals. Typically, shippers face $150 to $350 demurrage and detention fees assessed daily by the ocean … Full story available on Benzinga.
   Exclusive: Applied Genetic's CEO Talks Partnerships, Politics, Pipeline  2020/01/31 13:20:19 Benzinga
In the last year, sell-side analysts have shown confidence in Applied Genetic Technologies Corp (NASDAQ: AGTC ) with a series of upgrades and initiations. BMO, Chardan, Janney and Roth all bought into the biotech, and the company has yet to disappoint. Shares traded under the $3 level a year ago and nearly popped over $10 earlier this month. The stock currently trades around $6.50 a share. AGTC's Pipeline At AGTC’s Jan. 28 R&D Day, the biotech reported sustained positive data for its lead candidate XLRP in a Phase 1/2 trial for X-linked retinitis pigmentosa. XLRP is an orphan drug targeting 20,000 patients across the combined U.S. and European markets. “We’re really concentrating on and moving forward in the next stage, which is the pivotal trial,” AGTC President and CEO Sue Washer told Benzinga. The company previously reported “signs of biologic activity” from its other candidate, ACHM, in achromatopsia. The indication affects 28,000 patients in the U.S. and Europe. “Both patient populations are robust patient populations,” the CEO said.
  The Daily Biotech Pulse:アステラスが30億ドルでAudentesを購入、Applied Geneticsの最高医療責任者が辞任、Axsome Acesミッドステージ試験」 The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial  2019/12/03 07:59:00 Benzinga
「以下は、過去24時間にわたるバイオテクノロジー分野の主要な開発のまとめです。ピーク時のスケーリング(12週間で52週間の高値に達したバイオテック株…
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. …
   Applied Genetic Notches Sell-Side Upgrade After Releasing Interim Study Data  2019/09/30 16:03:32 Benzinga
Biotechnology company Applied Genetic Technologies Corp (NASDAQ: AGTC ) presented interim six-month data Thursday for the Phase 1/2 XLRP program in X-linked retinitis pigmentosa, turning BMO Capital Markets bullish on the stock. The Analyst Matthew Luchini upgraded Applied Genetics from Market Perform to Outperform rating with a price target lifted from $5 to $9. The Thesis Applied Genetic's interim six-month data for eight patients dosed peripherally showed stable visual function supported by visual field sensitivity and visual acuity assessments, Luchini said in a Friday note. (See his track record here .) Other highlights from the release include four of … Full story available on Benzinga.com
   Applied Genetic Technologies (AGTC) Reports Q4 Loss, Lags Revenue Estimates  2019/09/26 21:35:04 Zacks Investment Research
Applied Genetic Technologies (AGTC) delivered earnings and revenue surprises of -13.73% and -42.82%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
   Analysts Estimate Applied Genetic Technologies (AGTC) to Report a Decline in Earnings: What to Look Out for  2019/09/02 14:30:11 Zacks Investment Research
Applied Genetic Technologies (AGTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Is Applied Genetic Technologies (AGTC) Stock Outpacing Its Medical Peers This Year?  2019/06/13 13:30:16 Zacks Investment Research
Is (AGTC) Outperforming Other Medical Stocks This Year?

calendar